← Open Payments lookup

MARY CURLL: Open Payments

NPI 1174528319 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,834 in 84 payments from 18 companies in 2025. Trend: 2023 $2,466 · 2024 $2,972 · 2025 $1,834

Food & beverage: $1,834
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$300
Bayer Healthcare Pharmaceuticals Inc.13$269
ABBVIE INC.15$246
AstraZeneca Pharmaceuticals LP4$227
Amgen Inc.10$144
Novo Nordisk Inc5$124
Otsuka America Pharmaceutical, Inc.6$117
Boehringer Ingelheim Pharmaceuticals, Inc.3$71
Lilly USA, LLC3$71
Phathom Pharmaceuticals, Inc.3$53

Products named: CAPLYTA, Kerendia, VRAYLAR, AIRSUPRA, REXULTI, OTEZLA, JARDIANCE, MOUNJARO.

Industry payments across TX — which companies pay providers there.